Albumin as a Prognostic Indicator in Pre-Intubated Patients With SARS-CoV-2: A Retrospective, Multi-Institutional Study
Open Access
- 6 October 2021
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 13 (10)
Abstract
Much effort has been placed on evaluating serological tests that can predict worsening prognosis in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Endotracheal intubation in SARS-CoV-2 is associated with a higher risk of mortality. While studies have evaluated serological markers that can predict worsening prognosis, the likelihood of intubation in these patients has not been evaluated. The objective of this study was to determine if any serum marker corresponded to oxygen escalation or de-escalation in SARS-CoV-2-infected pre-intubated patients. This retrospective study reviewed 1,754 SARS-CoV-2 patients in the New York City Health and Hospitals Corporation (NYCHHC) system who required non-invasive positive pressure ventilation (NIPPV) such as continuous positive airway pressure or bilevel positive airway pressure. All patients were above the age of 18, were not terminally ill and requiring hospice care, and were admitted to the NYCHHC system between March 1, 2020 and May 17, 2020. SARS-CoV-2 serological labs were collected for five days for patients initiated on NIPPV, such that day one was 24 hours after NIPPV initiation. Multivariate and univariate linear regression modeling on this population cohort was remarkable for a significant association between serum albumin levels and oxygen escalation or de-escalation from NIPPV. We conclude that serum albumin level may have further utility in predicting oxygen escalation in pre-intubated patients with SARS-CoV-2, especially in a low-resource and high-demand setting.Keywords
This publication has 13 references indexed in Scilit:
- Biomarkers Predictive of Extubation and Survival of COVID-19 PatientsCureus, 2021
- Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 ScoreCritical Care Research and Practice, 2021
- Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control StudyJournal of Clinical Medicine Research, 2021
- Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19PLOS ONE, 2021
- Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortalityERJ Open Research, 2021
- Association of inflammatory markers with the severity of COVID-19: A meta-analysisInternational Journal of Infectious Diseases, 2020
- Liver Function Tests Profile in COVID-19 Patients at the Admission Time: A Systematic Review of Literature and Conducted ResearchesAdvanced Biomedical Research, 2020
- Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up StudyPLOS ONE, 2016
- Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset feverBMC Pulmonary Medicine, 2015
- Effectiveness of Noninvasive Positive Pressure Ventilation in the Treatment of Acute Respiratory Failure in Severe Acute Respiratory SyndromeChest, 2004